This is a news story, published by Yahoo, that relates primarily to Pfizer news.
For more Pfizer news, you can click here:
more Pfizer newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Yahoo, you can click here:
more news from YahooOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Pfizer. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest PfizerForAll news, specific medicine brands news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Pfizer IncReuters
•79% Informative
Pfizer launched PfizerForAll to help patients get access to treatments like Paxlovid and migraine pill Nurtec .
It can also help them find vaccines for respiratory illnesses like COVID , flu, respiratory syncytial virus ( RSV ) and pneumonia.
Investors have fled from Pfizer as the market for its COVID-19 vaccine and treatment has shrunk by billions of dollars a year.
VR Score
87
Informative language
91
Neutral language
78
Article tone
informal
Language
English
Language complexity
60
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links